Acquired severe hypercholesterolemia and hypoalphalipoproteinemia

Journal of Clinical Lipidology

Volumn 3, Issue 6, 2009, Pages 393-397

  Awan, Zuhier ^a   Bailey, Dana ^a   Hafiane, Anouar ^a   Genest, Jacques ^a  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN; C REACTIVE PROTEIN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CASE REPORT; CATARACT; CORONARY ARTERY DISEASE; DIABETIC NEUROPATHY; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOALPHALIPOPROTEINEMIA; HYPONATREMIA; LECITHIN CHOLESTEROL ACYLTRANSFERASE DEFICIENCY; LIFESTYLE; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEINURIA; SEROLOGY;

EID: 71549124327     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2009.10.001     Document Type: Article

References (16)

1. Krimbou L., Marcil M., Davignon J., and Genest J. Interaction of lecithin:cholesterol acyltransferase (LCAT)-alpha 2-macroglobulin complex with low density lipoprotein receptor-related protein (LRP). Evidence for an alpha 2-macroglobulin/LRP receptor-mediated system participating in LCAT clearance. J Biol Chem 276 (2001) 33241-33248
2. Chen C.H., and Albers J.J. Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin:cholesterol acyltransferase activity. J Lipid Res 23 (1982) 680-691
3. Marais A. Familial hypercholesterolaemia. Clin Biochem Rev 25 (2004) 49-68
4. Horton J., Cohen J., and Hobbs H. Molecular biology of PCSK9: its role in LDL metabolism. Trends Biochem Sci 32 (2007) 71-77
5. Miller M., and Zhan M. Genetic determinants of low high-density lipoprotein cholesterol. Curr Opin Cardiol 19 (2004) 380-384
6. Brien S., and Katzmarzyk P. Physical activity and the metabolic syndrome in Canada. Appl Physiol Nutr Metab 31 (2006) 40-47
7. Alwaili K., Alrasadi K., Awan Z., and Genest J. Approach to the diagnosis and management of lipoprotein disordersq. Curr Opin Endocrinol Diabetes Obes 16 (2009) 132-140
8. Miller J. Dyslipoproteinaemia of liver disease. Baillieres Clin Endocrinol Metab 4 (1990) 807-832
9. Soros P., Bottcher J., Maschek H., Selberg O., and Muller M. Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia. Hepatology 28 (1998) 1199-1205
10. Seidel D., Alaupovic P., and Furman R. A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. J Clin Invest 48 (1969) 1211-1223
11. DeMartiis M., Barlattani A., Parenzi A., and Sebastiani F. Pattern of lecithin-cholesterol-acyltransferase (L-CAT) activity in the course of liver cirrhosis. J Intern Med Res 11 (1983) 232-238
12. Sorokin A., Brown J., and Thompson P. Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: a systematic review. Atherosclerosis 194 (2007) 293-299
13. Zhu X., Herzenberg A., Eskandarian M., et al. A acyltransferase (LCAT)-deficient mouse expressing predominatly LpX is associated with spontaneous glomerulopathy. Am J Pathol 165 (2004) 1269-1278
14. Kronenberg F. Dyslipidemia and nephrotic syndrome: recent advances. J Ren Nutr 15 (2005) 195-203
15. Vaziri N., Liang K., and Parks J. Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome. Am J Physiol Renal Physiol 280 (2001) F823-F828
16. Joven J., Villabona C., Vilella E., Masana L., Alberti R., and Valles M. Abnormalities of lipoprotein metabolism in patients with nephrotic syndrome. N Engl J Med 323 (1990) 579-584